Skip to main content

Table 1 Baseline characteristics and HOMA-IR in patients with ischemic stroke and controls

From: Homeostasis model assessment of insulin resistance and outcome of ischemic stroke in non-diabetic patients - a prospective observational study

 

Cases

Controls

 

n

Mean ± SEM

n

Mean ± SEM

p-value

Sex (ratio m/f)

441

1.37 ± 0.02

560

1.37 ± 0.02

0.84

Age (years)

441

56.1 ± 0.51

560

56.6 ± 0.44

0.44

Hypertension (%)

438

58 ± 2.4

559

36 ± 2.0

< 0.001

Smoking (%)

440

39 ± 2.3

560

18 ± 1.6

< 0.001

Atrial fibr (%)

396

11 ± 1.5

513

1 ± 0.4

< 0.001

CAD (%)

432

11 ± 1.5

560

0 ± 0

< 0.001

BMI (kg/m2)

433

26.1 ± 0.20

559

26.3 ± 0.17

0.30

Acute LDL (mmol/L)

395

3.35 ± 0.05

558

3.33 ± 0.04

0.75

Acute CRP (mg/L)

433

11.4 ± 0.98

550

5.92 ± 0.22

< 0.001

Acute p-glucose

441

5.69 ± 0.06

560

5.09 ± 0.03

< 0.001

3-month glucose

429

5.21 ± 0.03

560

5.09 ± 0.03

0.005

Acute insulin

441

14.3 ± 0.63

560

8.26 ± 0.39

< 0.001

3-month insulin

429

12.1 ± 0.40

560

8.26 ± 0.39

< 0.001

Acute HOMA-IRa

441

2.84 ± 0.18

560

1.43 ± 0.09

< 0.001

3-month HOMA-IRa

429

2.34 ± 0.11

560

1.43 ± 0.09

< 0.001

  1. If not otherwise stated, data are shown as means and ± SEM. In addition, n is shown as numbers vary due to missing data. Differences between cases and controls were examined by ANOVA. ns not significant, LDL low-density lipoprotein, BMI body mass index, CRP C-reactive protein, CAD History of Coronary Artery Disease before the event; Atrial fibr, Atrial Fibrillation before the event; Smoking, Current Smoking. agiven as geometric mean and ± SEM
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us